A citation-based method for searching scientific literature

Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
Times Cited: 130



D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004
Times Cited: 178




List of shared articles



Times cited

Germline testing for homologous recombination repair genes-opportunities and challenges.
Steffen Hirsch, Laura Gieldon, Christian Sutter, Nicola Dikow, Christian P Schaaf. Genes Chromosomes Cancer 2021
2

miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Danielle Pessôa-Pereira, Adriane Feijó Evangelista, Rhafaela Lima Causin, René Aloisio da Costa Vieira, Lucas Faria Abrahão-Machado, Iara Viana Vidigal Santana, Vinicius Duval da Silva, Karen Cristina Borba de Souza, Renato José de Oliveira-Silva, Gabriela Carvalho Fernandes,[...]. BMC Cancer 2020
2

Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.
Siddhartha Yadav, Fergus J Couch. Am Soc Clin Oncol Educ Book 2019
17

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Kandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Heather Rocha, Juliann M Savatt, Alyson E Evans, Loren M Butry,[...]. JAMA Netw Open 2018
78

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
70

Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries.
Natalia Teixeira, Simone Maistro, Maria Del Pilar Estevez Diz, Marian J Mourits, Jan C Oosterwijk, Maria Aparecida Koike Folgueira, Geertruida H de Bock. Maturitas 2017
2

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
Edenir I Palmero, Henrique C R Galvão, Gabriela C Fernandes, André E de Paula, Junea C Oliveira, Cristiano P Souza, Carlos E Andrade, Luis G C Romagnolo, Sahlua Volc, Maximiliano C Neto,[...]. Genet Mol Biol 2016
14

Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
Marieke Arts-de Jong, Geertruida H de Bock, Christi J van Asperen, Marian J E Mourits, Joanne A de Hullu, C Marleen Kets. Eur J Cancer 2016
38

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.
Alexandra J van den Broek, Karen de Ruiter, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen, Senno Verhoef, Marjanka K Schmidt. Eur J Hum Genet 2015
12


Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort.
Ava Kwong, Connie H N Wong, Dacita T K Suen, Michael Co, Allison W Kurian, Dee W West, James M Ford. World J Surg 2012
12

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.
Nancie Petrucelli, Mary B Daly, Gerald L Feldman. Genet Med 2010
182

Assessing women at high risk of breast cancer: a review of risk assessment models.
Eitan Amir, Orit C Freedman, Bostjan Seruga, D Gareth Evans. J Natl Cancer Inst 2010
261